2018³âµµ Á¦15Â÷ ºÎ»ê¿ï»ê°æ³² ³úÁ¹ÁßÇÐȸ Ãß°è½ÉÆ÷Áö¿ò : 2018-09-01±³À°ÀÏÀÚ : 2018-09-01
±³À°Àå¼Ò : ºÎ»ê °í½ÅÀÇ°ú´ëÇÐ °Àǵ¿ 2Ãþ ¼º»ê°ü ¹× 3Ãþ ȸÀǽÇ
±³À°ÁÖÁ¦ :
2018³âµµ Á¦15Â÷ ºÎ»ê¿ï»ê°æ³² ³úÁ¹ÁßÇÐȸ Ãß°è½ÉÆ÷Áö¿ò ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï»ê°æ³²Áöȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-277-1919
À̸ÞÀÏ :
stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 5,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
½Ä»ç 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 12:30~13:20 µî·Ï ¹× Á¡½É½Ä»ç ()
±âŸ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 13:20~13:30 Àλ縻 ¼º»ó¹Î(ºÎ¿ï°æ ³úÁ¹ÁßÇÐȸÀå)
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 13:30~14:00 Guildeline update: How do we define the value in diabetes care? ±Ç¼ö°æ(°í½Å´ëº¹À½º´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 14:00~14:30 Evidence-based Thinking about Type 2 Diabetes Therapy Based on Cardiovascular Outcomes ÀüÀ±°æ(ºÎ»ê´ëº´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 14:30~14:45 Pannel discussion ÇÏ»ï¿ÃÖ½ÂÈ£(ÇØ¿î´ë¹éº´¿ø(ÇÏ»ï¿) ¿ï»êµ¿°º´¿ø(ÃÖ½ÂÈ£))
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 14:45~15:15 Pro Cardiologist''s Perspectives: PFO closure ¹Ú¿ëÇö(¾ç»êºÎ»ê´ëº´¿ø ¼øȱ⳻°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 15:15~15:45 Cons Neurologist''s Perspectives: PFO closure ¾È¼ºÈ£(¾ç»êºÎ»ê´ëº´¿ø ½Å°æ°ú)
Åä·Ð 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 15:45~16:00 Pannel discussion ±ÇÁöÇö ½ÅÀç¿ë(¿ï»ê´ëº´¿ø(±ÇÁöÇö) ºÀ»ýº´¿ø(½ÅÀç¿ë))
ÈÞ½Ä 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 16:00~16:20 ÈÞ½Ä ()
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 16:20~16:50 Hypertension, Impact of 2017 AHA/ACC Guideline on Ischemic Stroke Patient Á¤¿äÇÑ(â¿øÆÄƼ¸¶º´¿ø ½Å°æ°ú)
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 16:50~17:20 Fever, Before Stroke and After Stroke ÀÌÁøÇü(°í½Å´ëº¹À½º´¿ø ½Å°æ°ú)
Åä·Ð 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 17:20~17:30 Pannel discussion ¼Á¤È ¾çÅÂÀÏ(ºÎ»ê¹éº´¿ø(¼Á¤È) µ¿ÀÇÀÇ·á¿ø(¾çÅÂÀÏ))
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 16:20~16:50 ³úÁ¹Áß °ü·Ã ¿µ»óÀÇ ÀÌÇØ ÀåȸÁÖ(ºÎ»ê¹éº´¿ø Stroke Coordinator)
±³À°½Ã°£ 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 16:50~17:20 ³úÁ¹Áß °ü·Ã ½ºÄÉÀÏÀÇ ÀÌÇØ ÀÓ¿©Áø(ºÎ»ê´ëº´¿ø ½É³úÇ÷°üÁýÁßÄ¡·á½Ç Unit Manager)
Åä·Ð 09¿ù 01ÀÏ 2Ãþ ¼º»ê°ü 17:20~17:30 Q & A ()